Clinical effect of bisphosphonate in patients with hormone receptor-positive early breast cancer: A nationwide real-world data analysis.

Breast · 2026 · PMC13237587 · PMID 41886884

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

After adjusting for age and other confounders, BP use was independently associated with improved OS, whereas RFS showed a trend toward benefit, particularly among patients aged ≥60 years.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.